Antitumor conjugates with polyamine vectors and their molecular mechanisms

Expert Opinion on Drug Delivery

Volumn 7, Issue 9, 2010, Pages 1049-1061

  Xie, Songqiang ^a   Wang, Jianhong ^a   Zhang, Yahong ^a   Wang, Chaojie ^a  

^a HENAN UNIVERSITY   (China)

Author keywords

antitumor agents; molecular mechanism; polyamine conjugates; polyamine transport system

Indexed keywords

10 DEACETYLPACLITAXEL; ACRIDINE DERIVATIVE; ANTHRACENE DERIVATIVE; ANTINEOPLASTIC AGENT; AZIRIDINE DERIVATIVE; BENZOXADIAZOLE; CAMPTOTHECIN; CHLORAMBUCIL; ENEDIYENE DERIVATIVE; F 14512; MATUPORAMINE DERIVATIVE; NAPHTHALIMIDE DERIVATIVE; NAPHTHQUINONE DERIVATIVE; NITROIMIDAZOLE DERIVATIVE; PACLITAXEL; PHENYLXANTHENE; PODOPHYLLOTOXIN; POLYAMINE; PROTOBERBERINE; PUTRESCINE; SPERMIDINE; SPERMINE; SQUALAMINE; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE PHASE; CELL CYCLE PROGRESSION; CELL MEMBRANE; CHRONIC LYMPHATIC LEUKEMIA; DNA BINDING; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DNA INTERACTION; DRUG STRUCTURE; DRUG TRANSPORT; HUMAN; NONHUMAN; REVIEW; SOLID TUMOR; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CELL MEMBRANE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; NEOPLASMS; POLYAMINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77955908177     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.2010.504205     Document Type: Review

References (75)

1. Thomas T, Thomas TJ. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci 2001;58:244-258
2. Casero RA Jr, Woster PM. Recent advances in the development of polyamine analogues as antitumor agents. J Med Chem 2009;52:4551-4573
3. Prakash NJ, Schechter PJ, Grove J, et al. Effect of alpha- difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on L1210 leukemia in mice. Cancer Res 1978;38:3059-3062
4. Mitchell JL, Thane TK, Sequeira JM, et al. Unusual aspects of the polyamine transport system affect the design of strategies for use of polyamine analogues in chemotherapy. Biochem Soc Trans 2007;35:318-321
5. Palmer AJ, Wallace HM. The polyamine transport system as a target for anticancer drug development. Amino Acids 2010;38:415-422
6. Satriano J, Isome M, Casero RA Jr, et al. Polyamine transport system mediates agmatine transport in mammalian cells. Am J Physiol Cell Physiol 2001;281:329-334
7. Weeks RS, Vanderwerf SM, Carlson CL, et al. Novel lysine-spermine conjugate inhibits polyamine transport and inhibits cell growth when given with DFMO. Exp Cell Res 2000;261:293-302
8. Burns MR, Graminski GF, Weeks RS, et al. Lipophilic lysine-spermine conjugates are potent polyamine transport inhibitors for use in combination with a polyamine biosynthesis inhibitor. J Med Chem 2009;52:1983-1993
9. Gardner RA, Delcros JG, Konate F, et al. N1-substituent effects in the selective delivery of polyamine conjugates into cells containing active polyamine transporters. J Med Chem 2004;47:6055-6069
10. Phanstiel O, Kaur N, Delcros JG. Structure-activity investigations of polyamine anthracene conjugates and their uptake via the polyamine transporter. Amino Acids 2007;33:305-313
11. Wang C, Delcros JG, Cannon L, et al. Defining the molecular requirements for the selective delivery of polyamine conjugates into cells containing active polyamine transporters. J Med Chem 2003;46:5129-5138
12. Wang C, Delcros JG, Biggerstaff J, et al. Molecular requirements for targeting the polyamine transport system. Synthesis and biological evaluation of polyamine-anthracene conjugates. J Med Chem 2003;46:2672-2682
13. Wang C, Delcros JG, Biggerstaff J, et al. Synthesis and biological evaluation of N1-(anthracen-9-ylmethyl)triamines as molecular recognition elements for the polyamine transporter. J Med Chem 2003;46:2663-2671 (Pubitemid 36702535)
14. Seiler N. Pharmacological aspects of cytotoxic polyamine analogs and derivatives for cancer therapy. Pharmacol Ther 2005;107:99-119
15. Cullis PM, Green RE, Merson-Davies L, et al. Probing the mechanism of transport and compartmentalisation of polyamines in mammalian cells. Chem Biol 1999;6:717-729
16. Dot J, Lluch M, Blanco I, et al. Polyamine uptake in cultured astrocytes: characterization and modulation by protein kinases. J Neurochem 2000;75:1917-1926
17. Raksajit W, Yodsang P, Maenpaa P, et al. Characterization of spermidine transport system in a cyanobacterium, synechocystis sp. PCC 6803. J Microbiol Biotechnol 2009;19:447-454
18. Kruczynski A, Vandenberghe I, Pillon A, et al. Preclinical activity of F14512, designed to target tumors expressing an active polyamine transport system. Invest News Drugs 2009; doi 10.1007/s10637-009-9328-3
19. Kuramoto N, Inoue K, Takano K, et al. A possible novel mechanism underlying temperature-dependent uptake of [3H] spermidine in nuclear fractions of murine brain. Brain Res 2003;981:78-84
20. Porter CW, Miller J, Bergeron RJ. Aliphatic chain length specificity of the polyamine transport system in ascites L1210 leukemia cells. Cancer Res 1984;44:126-128
21. Seiler N, Delcros JG, Moulinoux JP. Polyamine transport in mammalian cells. An update. Int J Biochem Cell Biol 1996;28:843-861
22. Seiler N, Dezeure F. Polyamine transport in mammalian cells. Int J Biochem 1990;22:211-218
23. Belting M, Persson S, Fransson LA. Proteoglycan involvement in polyamine uptake. Biochem J 1999;338:317-323
24. Welch JE, Bengtson P, Svensson K, et al. Single chain fragment anti-heparan sulfate antibody targets the polyamine transport system and attenuates polyamine-dependent cell proliferation. Int J Oncol 2008;32:749-756
25. Soulet D, Gagnon B, Rivest S, et al. A fluorescent probe of polyamine transport accumulates into intracellular acidic vesicles via a two step mechanism. J Biol Chem 2004;279:49355-49366
26. Xie S, Cheng P, Liu G, et al. Synthesis and bioevaluation of N-(arylalkyl)-Homospermidine conjugates. Bioorg Med Chem Lett 2007;17:4471-4475
27. Xie SQ, Wang JH, Ma HX, et al. Polyamine transporter recognization and antitumor effects of anthracenymethyl homospermidine. Toxicology 2009;263:127-133
28. Fischer FG, Bohn H. Die Giftsekrete der Vogelspinnen; (Poisonous secretions of bird spiders). Ann Chem 1957;603:235-250
29. Usherwood PNR. Interaction of spider toxins with arthropod and mammalian glutamate receptors. In: Jenner P, editor. Neurotoxins and their pharmacological implications. Raven Press, New York; 1987. p. 133-151
30. Williams DE, Lassota P, Andersen RJ. Motuporamines A to C, cytotoxic alkaloids isolated from the marine sponge Xestospongia exigua (Kirkpatrick). J Org Chem 1998;63:4838-4841
31. Roskelley C, Williams DE, McHardy L, et al. Inhibition of tumor cell invasion and angiogenesis by motuporamines. Cancer Res 2001;61:6788-6794
32. Moore KS, Wehrli S, Roder H, et al. Squalamine, an aminosterol antibiotic from the shark. Proc Natl Acad Sci 1993;90:1354-1358
33. Sills AK Jr, Williams JI, Tyler BM, et al. Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculature. Cancer Res 1998;58:2784-2792
34. Singh R, Sharma M, Joshi P, Rawat DS. Anticancer agents. Med Chem 2008;8:603-617
35. Pastre D, Pietrement O, Landousy F, et al. A new approach to DNA bending by polyamines and its implication in DNA condensation. Eur Biophys J 2006;35:214-223
36. Holley JL, Mather A, Wheelhouse RT, et al. Targeting of tumor cells and DNA by a chlorambucil-spermidine conjugate. Cancer Res 1992;52:4190-4195
37. Holley JL, Mather A, Cullis PM, et al. Uptake and cytotoxicity of novel nitroimidazole polyamine conjugates in Ehrlich ascites tumour cells. Biochem Pharmacol 1992;43:763-769
38. Eiseman JL, Rogers FA, Guo Y, et al. Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9- diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer. Cancer Res 1998;58:4864-4870
39. Delcros J, Tomasi S, Carrington S, et al. Effect of spermine conjugation on the cytotoxicity and cellular transport of acridine. J Med Chem 2002;45:5098-5111
40. Suzuki I, Shigenaga A, Nemoto H, et al. Synthesis and DNA damaging ability of enediynepolyamine conjugates. Tetrahedron Lett 2004;14:1955-1959
41. Cunha AS, Lima ELS, Pinto AC, et al. Synthesis of novel naphtoquinone-spermidine conjugates and their effects on DNA-topoisomerases and II-a. J Braz Chem Soc 2006;17:439-442
42. Dallavalle S, Giannini G, Alloatti D, et al. Synthesis and cytotoxic activity of polyamine analogues of camptothecin. J Med Chem 2006;49:5177-5186
43. Pang JY, Long YH, Chen WH, et al. Amplification of DNA-binding affinities of protoberberine alkaloids by appended polyamines. Bioorg Med Chem Lett 2007;17:1018-1021
44. Guminski Y, Grousseaud M, Cugnasse S, et al. Synthesis of conjugated spermine derivatives with 7-nitrobenzoxadiazole (NBD), rhodamine and bodipy as new fluorescent probes for the polyamine transport system. Bioorg Med Chem Lett 2009;19:2474-2477
45. Annereau JP, Brel V, Dumontet C, et al. A fluorescent biomarker of the polyamine transport system to select patients with AML for F14512 treatment. Leuk Res 2010; doi:10.1016/j.leukres
46. Tian ZY, Xie SQ, Du YW, et al. Synthesis, cytotoxicity and apoptosis of naphthalimide polyamine conjugates as antitumor agents. Eur J Med Chem 2009;44:393-399
47. Franceschin M, Maria LC, Pascucci E, et al. The number and distances of positive charges of polyamine side chains in a series of perylene diimides significantly influence their ability to induce G-quadruplex structures and inhibit human telomerase. Bioorg Med Chem 2008;16:2292-2304
48. Battaglia A, Guerrini A, Baldelli E, et al. Synthesis of 7- and 10-spermine conjugates of paclitaxel and 10-deacetyl-paclitaxel as potential prodrugs. Tetrahedron Lett 2006;47:2667-2670
49. Barret J, Kruczynski A, Vispe S, et al. F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system. Cancer Res 2008;68:9845-9853
50. Kaur N, Delcros JG, Imran J, et al. A comparison of chloroambucil- and xylene-containing polyamines leads to improved ligands for accessing the polyamine transport system. J Med Chem 2008;51:1393-1401
51. Wang J, Xie S, Li Y, et al. Synthesis and evaluation of unsymmetrical polyamine derivatives as antitumor agents. Bioorg Med Chem 2008;16:7005-7012
52. Delcros JG, Tomasi S, Duhieu S, et al. Effect of polyamine homologation on the transport and biological properties of heterocyclic amidines. J Med Chem 2006;49:232-245
53. Crighton D, Ryan KM. Splicing DNA-damage responses to tumour cell death. Biochimica et Biophysica Acta 2004;1705:3-15
54. Roos WP, Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol Med 2006;12:440-450
55. Tian ZY, Ma HX, Xie SQ, et al. Synthesis, DNA binding and topoisomerase inhibition of mononaphthalimide homospermidine derivatives. Chin Chem Lett 2008;19:509-512
56. Nasizadeh S, Myhre L, Thiman L, et al. Importance of polyamines in cell cycle kinetics as studied in a transgenic system. Exp Cell Res 2005;308:254-264
57. Fredlund JO, Johansson MC, Dahlberg E, et al. Ornithine decarboxylase and S-adenosylmethionine decarboxylase expression during the cell cycle of Chinese hamster ovary cells. Exp Cell Res 1995;216:86-92
58. Thomas TJ, Shah N, Thomas T. Polyamine biosynthetic pathway as a cell cycle target for breast cancer therapy. Molecular targets and cancer therapeutics: discovery, development and clinical validation. Proceedings of AACR-NCI-EORTC International Conference; Washington, DC; 1999. p. 28-29
59. Alm K, Berntsson PS, Kramer DL, et al. Treatment of cells with the polyamine analog N1,N11-diethylnorspermine retards S phase progression within one cell cycle. Eur J Biochem 2000;267:4157-4164
60. Xie SQ, Liu GC, Ma YF, et al. Synergistic antitumor effects of anthracenylmethyl homospermidine and alpha-difluoromethylornithine on promyelocytic leukemia HL60 cells. Toxicol In Vitro 2008;22:352-358
61. Xie SQ, Wu YL, Cheng PF, et al. A novel homospermidine conjugate inhibits growth and induces apoptosis in human hepatoma cells. Acta Pharmacol Sin 2007;28:1827-1834
62. Tian ZY, Xie SQ, Mei ZH, et al. Conjugation of substituted naphthalimides to polyamines as cytotoxic agents targeting the Akt/mTOR signal pathway. Org Biomol Chem 2009;7:4651-4660
63. Bolognesi ML, Calonghi N, Mangano C, et al. Parallel synthesis and cytotoxicity evaluation of a polyamine-quinone conjugates library. J Med Chem 2008;51:5463-5467
64. Palmer AJ, Ghani RA, Kaur N, et al. A putrescine-anthracene conjugate: a paradigm for selective drug delivery. Biochem J 2009;424:431-438
65. Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 2009;9:153-166
66. Chulu JL, Liu HJ. Recent patents on cell cycle regulatory proteins. Recent Pat Biotechnol 2009;3:1-9
67. Abukhdeir AM, Park BH. P21 and p27: roles in carcinogenesis and drug resistance. Expert Rev Mol Med 2008;10:e19
68. Satyanarayana A, Kaldis P. Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene 2009;28:2925-2939
69. Dowling RJ, Pollak M, Sonenberg N. Current status and challenges associated with targeting mTOR for cancer therapy. Bio Drugs 2009;23:77-91
70. Kroczynska B, Kaur S, Platanias LC. Growth suppressive cytokines and the AKT/mTOR pathway. Cytokine 2009;48:138-143
71. Zhao XF, Gartenhaus RB. Phospho-p70S6K and cdc2/cdk1 as therapeutic targets for diffuse large B-cell lymphoma. Expert Opin Ther Targets 2009;13:1085-1093
72. Ralton LD, Bestwick CS, Milne L, et al. Bisnaphthalimidopropyl spermidine induces apoptosis within colon carcinoma cells. Chem Biol Interact 2009;177:1-6
73. Hail H Jr. Mitochondrial reactive oxygen species affect sensitivity to curcumin-induced apoptosis. Free Radic Biol Med 2008;44:1382-1393
74. Marcocci L, Casadei M, Faso C, et al. Inducible expression of maize polyamine oxidase in the nucleus of MCF-7 human breast cancer cells confers sensitivity to etoposide. Amino Acids 2007;34:403-412
75. Richardson A, Kaye SB. Pharmacological inhibition of the Bcl-2 family of apoptosis regulators as cancer therapy. Curr Mol Pharmacol 2008;1:244-254